IMMUCELL CORP /DE/
Company Information
Industry In Vitro & In Vivo Diagnostic Substances
SIC Code 2835
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 56 EVERGREEN DR, PORTLAND, ME, 04103
Mailing Address 56 EVERGREEN DRIVE, PORTLAND, ME, 04103
Phone 2078782770
Fiscal Year End 1231
EIN 010382980
Financial Overview
FY2025
$17.58M
Total Liabilities
$-0.26
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 10-K Annual financial report | March 30, 2026 | View on SEC |
| 4 Insider stock transaction report | March 24, 2026 | View on SEC |
| 4/A Insider transaction amendment | March 23, 2026 | View on SEC |
| 8-K Current report of material events | March 18, 2026 | View on SEC |
| 8-K Current report of material events | March 4, 2026 | View on SEC |
| 8-K Current report of material events | February 9, 2026 | View on SEC |
| 8-K Current report of material events | February 2, 2026 | View on SEC |
| 4 Insider stock transaction report | January 29, 2026 | View on SEC |
| 4 Insider stock transaction report | January 29, 2026 | View on SEC |
| 4 Insider stock transaction report | January 29, 2026 | View on SEC |
Annual Reports
10-K March 30, 2026
- Strategic pivot to focus exclusively on flagship product First Defense® to stabilize cash flow.
- Planned 20-30% production increase for First Defense® by repurposing existing manufacturing space.
Insider Trading
BUY 2 insiders
7 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2835)
Insight Molecular Diagnostics Inc.
IMDX In Vitro & In Vivo Diagnostic Substances
ACHIEVE LIFE SCIENCES, INC.
ACHV In Vitro & In Vivo Diagnostic Substances
Q/C TECHNOLOGIES, INC.
QCLS In Vitro & In Vivo Diagnostic Substances
Cardio Diagnostics Holdings, Inc.
CDIO In Vitro & In Vivo Diagnostic Substances
MYRIAD GENETICS INC
MYGN In Vitro & In Vivo Diagnostic Substances
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.